Elon Musk: First Neuralink User Controls Mouse with Thoughts

Elon Musk, the founder of Neuralink, announced late on Monday that the first patient implanted with a brain chip from the business Neuralink appeared to have fully recovered and can operate a computer mouse with their thoughts.

Let’s read the news and find out more

Elon Musk: First Neuralink User Controls Mouse with Thoughts

In May 2023, Nerualink’s chip was authorized for use in human clinical trials by the US Food and Drug Administration (FDA). After being granted permission to recruit participants for a human trial in September, the company successfully implanted a chip in its first human patient last month.

According to Neuralink, the project employs a robot to perform a surgical placement of a brain-computer interface implant in a brain region that governs the movement intentions.

The primary objective of this research is to enable patients to control a computer cursor or keyboard by thought.

Musk stated during a Spaces event on the social media platform X, “Progress is good, and the patient seems to have made a full recovery, with no ill effects that we are aware of. The patient is able to move a mouse around the screen by just thinking,”

Also, read “Microsoft Invests $2.1 Billion to Grow AI in Spain.”

According to Elon Musk, Neuralink is now looking to get as many mouse button clicks from the patient as possible. Musk claims that Neuralink will enable quick surgical insertions of its chip devices to treat diseases like obesity, schizophrenia, depression, and autism. Musk has high hopes for this business.

Neuralink, which was estimated to be worth $5 billion in the past year, has frequently been the target of criticism for its safety procedures.

Neuralink’s first human brain chip implant marks a significant step in brain-computer interface technology. This development could revolutionize treatments for paralysis and neurological conditions.

The chip, placed in the brain by a robot, aims to let users control devices with their thoughts.

Beyond medical applications, this technology raises ethical and safety questions, reflecting the need for careful oversight.

Also, read “U.S. Awards $1.5 Billion to Chipmaker GlobalFoundries“

The technology could offer new ways for people with disabilities to interact with the world. It also opens discussions on the ethical implications of such advancements.

As we move forward, it’s crucial to balance innovation with considerations of safety and morality, ensuring that these groundbreaking technologies enhance lives while respecting individual autonomy and privacy.

Neuralink’s progress showcases the potential of merging human cognition with artificial intelligence, promising profound impacts on medicine and technology.